Current Global Occurrence of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Infections in Hospitalized Patients: A Literature Review

Martinair Santana da Silva *

Postgraduate Program in Sciences and Health, Federal University of Ceará (UFC), Sobral, CE, Brazil.

Júlio César Sousa Prado

Postgraduate Program in Sciences and Health, Federal University of Ceará (UFC), Sobral, CE, Brazil.

Maria Walcleanes Magalhães de Oliveira

Postgraduate Program in Sciences and Health, Federal University of Ceará (UFC), Sobral, CE, Brazil.

Patrick Veras Quelemes

Postgraduate Program in Dentistry, Federal University of Piauí (UFPI), Teresina, PI, Brazil.

Francisco Cesar Barroso Barbosa

Postgraduate Program in Sciences and Health, Federal University of Ceará (UFC), Sobral, CE, Brazil.

*Author to whom correspondence should be addressed.


Antimicrobial resistance (AMR) is an escalating global issue. One of the primary resistance mechanisms is the ability of microbes to deactivate antimicrobial drugs through the production of expanded-spectrum β-lactamases enzymes (ESBL), such as carbapenemases. Among the pathogens associated with multidrug resistance, Klebsiella pneumoniae has a high frequency, particularly in hospital settings. This study presents a narrative review of the literature from the scientific databases of the National Library of Medicine (PubMed) and the Cochrane Library on the occurrence of carbapenem-resistant K. pneumoniae (CRKP) infections in hospitalized patients, identifying current studies that may contribute to understand the spread of resistant bacteria. The review was conducted in September 2023 with the aim of summarizing evidence. Inclusion and exclusion criteria were applied, and 20 articles were included, covering the continents of the America, Africa, Asia, and Europe, to select the most recent studies about CRKP. In the studies analyzed, nosocomial isolates predominantly originated from sputum samples, followed by urine and blood. Molecular analysis revealed that most microorganisms exhibiting resistance to carbapenems harbored the blaKPC, blaNDM, and blaOXA-48 genes. However, there is epidemiological variation among continents, underscoring the need for more knowledge about genetic diversity and the implementation of active surveillance culture programs to facilitate prompt action with appropriate therapy and minimal patient risk. These findings indicate a necessity for heightened vigilance by hospital infection control committees to prevent potential spread and outbreaks of bacteria carrying carbapenem resistance genes.

Keywords: Antibiotic resistance genes, nosocomial infections, carbapenem resistance, multidrug-resistant bacteria

How to Cite

Silva, M. S. da, Prado, J. C. S., Oliveira, M. W. M. de, Quelemes , P. V., & Barbosa , F. C. B. (2024). Current Global Occurrence of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Infections in Hospitalized Patients: A Literature Review. Archives of Current Research International, 24(5), 113–123.


Download data is not yet available.


WHO, World Health Organization. Health care without avoidable infections: the critical role of infection prevention and control; 2016. Accessed August 1,2023.

Brazil. National Health Surveillance Agency.Clinical Microbiology for the Control of Healthcar Associated Infection. Brasilia: Anvisa; 2015. Available:

Santajit SE, Indrawattana N. Mechanisms of Antimicrobial Resistance in SKAPE Pathogens. BioMed Research International Pesquisa BioMed internacional; 2016.

Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Bassetti M. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae: Importance of combination therapy. Clinical infectious diseases. 2012;55(7):943- 950.

Bush K. Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-negative infections. Critical care. 2010;14:1-8.

Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Stewar CD, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial agents and chemotherapy. 2001;45(4):1151-1161.

Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, Westblade LF Carbapenemase-producing organisms: A global scourge. Clinical infectious diseases. 2018;66(8):1290-1297.

Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clinical Infectious Diseases. 2019;69(Supplement_7):S521-S528.

Lee Y & Bradley N. Overview and insights into carbapenem allergy. Pharmacy. 2019; 7(3):110.

Santos WMD, & Secoli SR. Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase. Einstein (São Paulo). 2019;17:eGS4444.

Wyres KL, Lam MM & Holt KE. Population genomics of Klebsiella pneumoniae. Nature Reviews Microbiology. 2020;18(6): 344-359.

Zhang H, Johnson A, Zhang G, Yang Y, Zhang J, Li D, Xu Y. Susceptibilities of Gram-negative bacilli from hospital-and community-acquired intra-abdominal and urinary tract infections: A 2016–2017 update of the Chinese SMART study. Infection and Drug Resistance. 2019:905-914.

Ripabelli G, Tamburro M, Guerrizio G, Fanelli I, Flocco R, Scutellà M & Sammarco ML. Tracking multidrug-resistant Klebsiella pneumoniae from an Italian hospital: molecular epidemiology and surveillance by PFGE, RAPD and PCR-based resistance genes prevalence. Current microbiology. 2018;75:977-987.

Munita JM, Arias CA. Mechanisms of antibiotic resistance. Virulence mechanisms of bacterial pathogens. 2016; 481-511.

Chen D, Xiao L, Hong D, Zhao Y, Hu X, Shi S & Chen F. Epidemiology of resistance of carbapenemase‐producing Klebsiella pneumoniae to ceftazidime‐avibactam in a Chinese hospital. Journal of Applied Microbiology. 2022;132(1):237-243.

Zahedi Bialvaei A, Eslami P, Ganji L, Dolatyar Dehkharghani A, Asgari F, Koupahi H, Rahbar M. Prevalence and epidemiological investigation of mgrB-dependent colistin resistance in extensively drug resistant Klebsiella pneumoniae in Iran. Scientific Reports. 2023;13(1):10680.

Taha R, Mowallad A, Mufti A, Althaqafi A, Jiman-Fatani AA, El-Hossary D & Jawi N. H. Prevalence of Carbapenem-resistant Enterobacteriaceae in Western Saudi Arabia and increasing trends in the antimicrobial resistance of Enterobacteriaceae. Cureus. 2023;15(2).

Shen M, Chen X, He, J, Xiong L, Tian R, Yang G, Wu K. Antimicrobial resistance patterns, sequence types, virulence and carbapenemase genes of carbapenem-resistant Klebsiella pneumoniae clinical isolates from a tertiary care teaching hospital in Zunyi, China. Infection and Drug Resistance. 2023:637-649.

Wang T, Zhu Y, Zhu W, Cao M & Wei Q. Molecular characterization of class 1 integrons in carbapenem-resistant Enterobacterales isolates. Microbial Pathogenesis. 2023;177, 106051.

Soltani E, Hasani A., Rezaee MA, Nahandi MZ, Hasani A & Gholizadeh P . An alliance of carbapenem-resistant Klebsiella pneumoniae with precise capsular serotypes and clinical determinants: A disquietude in hospital setting. Canadian Journal of Infectious Diseases and Medical Microbiology; 2022.

Ghotaslou R, Salahi B, Naderi G & Alizadeh N. High Frequency of blaOXA-48like Producing Klebsiella pneumoniae Isolated from Nosocomial Infection in Azerbaijan, Iran. Infection & Chemotherapy. 2023;55(1):90.

Gondal AJ, Choudhry N, Bukhari H, Rizvi Z, Jahan S, Yasmin N. Estimation, Evaluation and Characterization of Carbapenem Resistance Burden from a Tertiary Care Hospital, Pakistan. Antibiotics. 2023;12(3): 525.

Afolayan AO, Rigatou A, Grundmann H, Pantazatou A, Daikos G & Reuter S. Three Klebsiella pneumoniae lineages causing bloodstream infections variably dominated within a Greek hospital over a 15-year period. Microbial Genomics. 2023;9(8): 001082.

Bovo F, Amadesi S, Palombo M, Lazzarotto T, Ambretti S, Gaibani P. Clonal dissemination of Klebsiella pneumoniae resistant to cefiderocol, ceftazidime/ avibactam, meropenem/vaborbactam and imipenem/relebactam co-producing KPC and OXA-181 carbapenemase. JAC-Antimicrobial Resistance. 2023;5(4): dlad099.

Nordmann P, Bouvier M & Poirel L. Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland. European Journal of Clinical Microbiology & Infectious Diseases. 2023;42(9):1145-1152.

Fischer P, Pandrea S, Grigorescu MD, Stefanescu H, Tefas C, Hadade A, Ionescu D. The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit. Digestive and Liver Disease. 2022;54(10):1385-1391.

Sarowska J, Choroszy-Krol I, Jama-Kmiecik A, Mączyńska B, Cholewa S & Frej-Madrzak M. Occurrence and characteristics of carbapenem-resistant Klebsiella pneumoniae strains isolated from hospitalized patients in Poland—A single centre study. Pathogens. 2022;11(8), 859.

Baraka K, Abozahra R, Haggag M M & Abdelhamid S M. Genotyping and molecular investigation of plasmid-mediated carbapenem resistant clinical Klebsiella pneumoniae isolates in Egypt. AIMS microbiology. 2023;9(2):228.

El-Kady RAEH, Elbaiomy MA, Elnagar RM. Molecular mechanisms mediating ceftazidime/avibactam resistance amongst carbapenem-resistant Klebsiella pneumoniae isolates from cancer patients. Infection and Drug Resistance. 2022;5929-5940.

Odewale G, Jibola-Shittu MY, Ojurongbe O, Olowe RA & Olowe OA. Genotypic Determination of Extended Spectrum β-Lactamases and Carbapenemase Production in Clinical Isolates of Klebsiella pneumoniae in Southwest Nigeria. Infectious Disease Reports. 2023;15(3): 339-353.

Flores C, Bianco K, de Filippis I, Clementino MM & Romão C M C. Genetic relatedness of NDM-producing Klebsiella pneumoniae co-occurring VIM, KPC, and OXA-48 enzymes from surveillance cultures from an intensive care unit. Microbial drug resistance. 2020;26(10): 1219-1226.

Vivas R, Dolabella SS, Barbosa AAT, Jain S. Prevalence of Klebsiella pneumoniae carbapenemase-and New Delhi metallo-beta-lactamase-positive K. pneumoniae in Sergipe, Brazil, and combination therapy as a potential treatment option. Revista da Sociedade Brasileira de Medicina Tropical. 2020;53,:e20200064.

Kiffer CR, Rezende TF, Costa-Nobre DT, Marinonio ASS, Shiguenaga LH, Kulek DN O & Pillonetto M. A 7-year Brazilian national perspective on plasmid-mediated carbapenem resistance in enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex and the impact of the coronavirus disease 2019 pandemic on their occurrence. Clinical Infectious Diseases. 2023;77(Supplement_1):S29-S37.

Estabrook M, Muyldermans A, Sahm D, Pierard D, Stone G, Utt E. Epidemiology of resistance determinants identified in meropenem-nonsusceptible Enterobacterales collected as part of a global surveillance study, 2018 to 2019. Antimicrobial Agents and Chemotherapy. 2023;67(5):e01406-22.

Abbas R, Chakkour M, Zein El Dine H, Obaseki EF, Obeid ST, Jezzini A, Ezzeddine Z. General Overview of Klebsiella pneumonia: Epidemiology and the Role of Siderophores in Its Pathogenicity. Biology. 2024;13(2):78.